Friday, March 16, 2018 6:43:57 PM
I frankly don't believe the company was at all concerned with safety. An investor who visited the company in Israel had been permitted to try a little of the cream, no telling how many others were. The requirement to do the trial with healthy people was probably required by authorities in Israel, but perhaps the U.S. FDA was asked as well. Personally I believe the authorities add a great deal of cost and time for such trials, other companies are selling cream with cannabis in it, but probably not as high a content, but my point is authorities know this, what would the harm have been if they used patients with psoriasis or other skin diseases in the Phase 1 trial and then have a Phase 2 portion where added patients were dosed at what was determined to be the most effective dosing level. Had that been done, the next step could have been a Pivotal Trial if the outcome was sufficient to warrant it.
Gary
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM